z-logo
Premium
Chronic treatment with otilonium bromide induces changes in L‐type Ca 2+ channel, tachykinins, and nitric oxide synthase expression in rat colon muscle coat
Author(s) -
Traini C.,
Cipriani G.,
Evangelista S.,
Santicioli P.,
FaussonePellegrini M.S.,
Vannucchi M.G.
Publication year - 2013
Publication title -
neurogastroenterology and motility
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.489
H-Index - 105
eISSN - 1365-2982
pISSN - 1350-1925
DOI - 10.1111/nmo.12197
Subject(s) - endocrinology , medicine , nitric oxide synthase , chemistry , receptor , nitric oxide , agonist , channel blocker , calcium
Background Otilonium bromide ( OB ) is a quaternary ammonium derivative used for the treatment of intestinal hypermotility and is endowed with neurokinin2 receptor ( NK 2r) antagonist and Ca 2+ channel blocker properties. Therefore, the possibility that OB might play a role in the neurokinin receptor/Substance‐P/nitric oxide ( NK r/ SP / NO ) circuit was investigated after chronic exposition to the drug. Methods Rats were treated with OB 2–20 mg kg −1 for 10 and 30 days. In the proximal colon, the expression and distribution of muscle NO synthase 1 ( NOS 1), NK 1r, NK 2r, SP and Ca v 1.2 subunit (for L‐type Ca 2+ channel) and the spontaneous activity and stimulated responses to NK 1r and NK 2r agonists were investigated. Key Results Immunohistochemistry showed a redistribution of NK 1r and L‐type Ca 2+ channel in muscle cells with no change of NK 2r at 30 days, a significant increase in muscle NOS 1 expression at 10 days and a significant decrease in the SP content early in the ganglia and later in the intramuscular nerve fibers. Functional studies showed no change in spontaneous activity but a significant increase in maximal contraction induced by NK 1r agonist. Conclusions & Inferences Chronic exposition to OB significantly affects the NK r/ SP / NO circuit. The progressive decrease in SP ‐expression might be the consequence of the persistent presence of OB , the increase of NOS 1 expression in muscle cells at 10 days in an attempt to guarantee an adequate NO production, and, at 30 days, the redistribution of the L‐type Ca 2+ channel and NK 1r as a sign to compensate the drug channel block by re‐cycling both of them. The physiological data suggest NK 1r hypersensitivity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here